Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826468) titled 'Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery' on Sept. 14.
Study Type: Observational
Primary Sponsor: Hopital de la Croix-Rousse
Condition:
Pregnancy
Cesarian Section
Lidocaine Toxicity
Neonatal
Urgent Cesarean Delivery
Fetal Drug Exposure
Transplacental Drug Transfer
Epidural Analgesia, Obstetric
Intervention:
Procedure: Category Lucas 1 cesarian section
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2025
Target Sample Size: 95
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT07826468
Disclaimer: Curated ...